Omar El-Charif

Omar El-Charif is a Research Fellow in the Department of Internal Medicine at Yale School of Medicine, participating in the Physician-Scientist Training Program. His work focuses on leveraging multi-omic data to develop predictive clinical tools for personalized medicine, with expertise in GWAS, transcriptomics, and functional genomics. He holds an MD from the University of Rochester School of Medicine (2022) and a BA from the University of Chicago (2016).

His research emphasizes understanding genetic and clinical factors influencing chemotherapeutic toxicities such as cisplatin-induced neurotoxicity and radiation-associated ototoxicity. Key contributions include studies on serum platinum levels, hypogonadism outcomes in cancer survivors, and metabolic consequences of chemotherapy.

• Awards: Distinction in Medical Education (2022), Doran J. Stephens Prize (2022), Alpha Omega Alpha (2022), Gold Humanism Award (2022)

His publications span oncology, pharmacogenomics, and survivorship care, with a focus on translating genomic insights into clinical practice. El-Charif is also dedicated to medical education and has been recognized for excellence in teaching and mentorship.